CCL2 and breast cancer: A previous study also showed that treatment of immunodeficient mice bearing mammary tumors with anti‐CCL2 antibodies resulted in significant inhibition of lung metastases and increase in survival, and the mechanism was attributed to the direct angiogenic effect of CCL2 29.